BRAZIL · HEALTHCARE
Saturday, May 30, 2026 — 03:00 BRT — By Adele Cardin
Key Facts
—The close: Grupo Fleury concluded its acquisition of the FEMME women’s-health laboratory chain on Friday after the antitrust regulator’s final approval earlier in May.
—The price: The enterprise value of R$207.5m ($41.3m) implies a 5.5x EBITDA multiple, falling to 3.3x with the expected synergies factored in.












